scutellarin has been researched along with Diabetic Retinopathy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JL; Gao, AS; Guo, XL; Li, N; Liu, XZ; Wang, TH; Wang, YF; Xiao, YG; Xu, M; Zhang, LC | 1 |
| Hu, Y; Ke, Z; Li, W; Li, X; Li, Y; Long, L; Long, T; Wang, L; Xiao, H; Ye, X; Yu, S | 1 |
| Ji, L; Lu, B; Mei, X; Ouyang, H; Wang, Z; Zhang, T | 1 |
| Chen, L; Deng, DY; Huang, P; Long, L; Luo, J; Tan, J; Wang, J; Yang, L; Zhang, LM; Zhou, W; Zhu, B | 1 |
4 other study(ies) available for scutellarin and Diabetic Retinopathy
| Article | Year |
|---|---|
Network pharmacology mechanism of Scutellarin to inhibit RGC pyroptosis in diabetic retinopathy.
Topics: Animals; Caspase 1; Diabetes Mellitus; Diabetic Retinopathy; Drugs, Chinese Herbal; Interleukin-18; Molecular Docking Simulation; Network Pharmacology; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats | 2023 |
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
Topics: Angiogenesis Inhibitors; Animals; Apigenin; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Glucuronates; Humans; Male; Rats; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases; Streptozocin; Vascular Endothelial Growth Factor A | 2019 |
Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Topics: Animals; Apigenin; Blood-Retinal Barrier; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Glucose; Glucuronates; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Microglia; NF-E2-Related Factor 2; Oxidative Stress; Retina; Tumor Necrosis Factor-alpha | 2019 |
Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Topics: Administration, Oral; Animals; Apigenin; Biological Availability; Caco-2 Cells; Chitosan; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Carriers; Drugs, Chinese Herbal; Erigeron; Glucuronates; Humans; Male; Nanoparticles; Rats, Sprague-Dawley; Retinal Vessels; Vascular Endothelial Growth Factor A; Vitamin B 12; Zebrafish | 2017 |